<DOC>
	<DOCNO>NCT02302768</DOCNO>
	<brief_summary>Over past 10 year , several clinical study suggest selenium supplementation may influence natural history AIT . Recently , Interferon gamma ( IFNγ ) -inducible chemokines ( CXCL-9 , -10 -11 ) show elevated AIT patient . The aim prospective , randomize , control study evaluate effect two different dos selenomethionine ( 80 160 mcg ) versus placebo euthyroid woman AIT , term reduction anti-thyroid antibody improvement thyroid hypoechogenicity , 24 month . Serum level selenium , CXCL-9 , -10 -11 regulator , Tumor necrosis factor alpha ( TNFα ) INFγ , thyroid function volume quality life AIT patient also evaluate .</brief_summary>
	<brief_title>Effect Semet ( 80 160 mcg ) Versus Placebo Euthyroid Patients With AIT</brief_title>
	<detailed_description />
	<mesh_term>Thyroiditis</mesh_term>
	<mesh_term>Thyroiditis , Autoimmune</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<criteria>Diagnosis chronic autoimmune thyroiditis define positivity anti thyroperoxidase and/or anti thyroglobulin antibody ( &gt; = 100 U/l ) thyroid hypoechogenicity Presence thyroid disease micronodules History malignancy past 5 year Drugs affect immune system and/or thyroid function Pregnancy detect screen followup .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>